Benzinga·2025-09-15 12:11Group 1: Opendoor Technologies Inc. - Jim Cramer recommended selling Opendoor Technologies Inc. shares, stating "We don't want to be in a meme stock" [1] - Opendoor shares experienced a decline of 13.8%, settling at $9.07 [5] Group 2: TeraWulf Inc. - TeraWulf announced major expansion plans and new financing initiatives related to its role in AI infrastructure on August 18 [2] - TeraWulf shares increased by 1.1%, closing at $10.76 [5] Group 3: Hubbell Incorporated - Cramer advised investors to stay long on Hubbell Incorporated, suggesting to wait for a price drop before buying [2] - Stephens & Co. analyst Tommy Moll reiterated an Overweight rating for Hubbell with a price target of $500 [2] - Hubbell shares fell by 3%, settling at $437.43 [5] Group 4: Lumentum Holdings Inc. - Cramer recommended selling half of Lumentum Holdings Inc. stock [3] - Barclays analyst Tom O'Malley maintained an Overweight rating for Lumentum and raised the price target from $135 to $165 [3] - Lumentum shares fell by 1.1%, closing at $163.02 [5] Group 5: Summit Therapeutics Inc. - Cramer indicated that it is time to move on from Summit Therapeutics [3] - Summit Therapeutics revealed updated overall survival results from the global Phase 3 HARMONi trial at the 2025 World Conference on Lung Cancer [3] - Summit Therapeutics shares rose by 1.8%, settling at $18.94 [5]